Short Stature - Prader-Willi Sindrome

HGH Treatment for Short Stature Caused by Prader-Willi Syndrome

Prader-Willi syndrome (PWS) is a disease caused by abnormalities of chromosome 15. It is a genetic condition that is caused by the absence of genes that are passed from the father. It is found in people of both sexes and can lead to low muscle tone, short stature, obesity, and even cognitive disabilities.

Children with PWS are often shorter than other children of the same age, and they generally have small hands and feet. Their bodies do not form muscle effectively, so they generally have low muscle densities. Additionally, they have problems deciding when they've eaten enough, often leading to a necessary strict diet and problems with obesity.

Human growth hormone treatment is commonly used for children with PWS. There are many effects of HGH that are of benefit to children with PWS. First, HGH caused a person to grow new muscle cells. Normally, children with PWS do not develop muscle cells properly, resulting in low muscle density. However, HGH promotes muscle cell growth, therefore increasing a child's muscle tone.

Another effect of HGH that is beneficial to children with PWS is its ability to promote bone growth. HGH can extend the height of a child until the time when their bones quit growing. This normally occurs during puberty, and, after puberty, the growing of bones is no longer possible. For this reason, it is better to treat a child as early as possible in order to encourage their reaching normal heights.

The final effect of HGH that is beneficial for children with PWS is its ability to promote fat loss and prevent obesity. HGH speeds up a person's metabolism and reduces the amount of carbohydrates that are stored in the fat reserves. This can be very beneficial for children with PWS because they will not gain excess weight when they overeat.